Literature DB >> 7114833

Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.

J Camí, J Segura, J E Baños, I Garcia, L Drobnic.   

Abstract

The urinary excretion of N-acetyl-beta-glucosaminidase was studied in healthy subjects during and after treatment with aminoglycosides. In terms of this parameter dibekacin appeared to be less nephrotoxic than gentamicin.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7114833      PMCID： PMC182065          DOI： 10.1128/AAC.21.6.1013

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Studies on glucosaminidase. 2. Substrates for N-acetyl-beta-glucosaminidase.

Authors:  J Borooah; D H Leaback; P G Walker
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

2.  Renal damage during treatment with antirheumatic drugs.

Authors:  P A Dieppe; D V Doyle; H C Burry
Journal:  Br Med J       Date:  1978-09-02

3.  Urinary excretion of acid hydrolases in disease.

Authors:  B Hultberg; N Nordén; P A Ockerman
Journal:  Scand J Clin Lab Invest       Date:  1972-10       Impact factor: 1.713

4.  Antibacterial activity of dibekacin against gentamicin-resistant organisms.

Authors:  M Hamada; Y Homma; T Tamamura; S Kondo
Journal:  Jpn J Antibiot       Date:  1977-02

5.  The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. II. Elevation in human excretion after aspirin and sodium salicylate.

Authors:  T D Lockwood; H B Bosmann
Journal:  Toxicol Appl Pharmacol       Date:  1979-06-30       Impact factor: 4.219

6.  Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.

Authors:  J M Wellwood; B G Ellis; R G Price; K Hammond; A E Thompson; N F Jones
Journal:  Br Med J       Date:  1975-08-16

7.  Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin.

Authors:  A Whelton; G G Carter; R L Stout; D V Herbst; H H Bryant; G Walker
Journal:  J Clin Pharmacol       Date:  1980 Aug-Sep       Impact factor: 3.126

8.  The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. I. Partial biochemical characterization and excretion in humans and release from the isolated perfused rat kidney.

Authors:  T D Lockwood; H B Bosmann
Journal:  Toxicol Appl Pharmacol       Date:  1979-06-30       Impact factor: 4.219

9.  Comparative nephrotoxicities of dibekacin, amikacin, and gentamicin in a rat model.

Authors:  L I Rankin; F C Luft; M N Yum; L L Isaacs
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191
  9 in total
  1 in total

1.  Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.

Authors:  J D Place; S G Thompson
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.